196 related articles for article (PubMed ID: 37000581)
1. Cardiovascular outcomes in patients with atrial fibrillation concomitantly treated with antiarrhythmic drugs and non-vitamin k antagonist oral anticoagulants.
Wu VC; Wang CL; Huang YC; Tu HT; Huang YT; Huang CH; Chen SW; Kuo CF; Hung KC; Chang SH
Europace; 2023 May; 25(5):. PubMed ID: 37000581
[TBL] [Abstract][Full Text] [Related]
2. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
Valembois L; Audureau E; Takeda A; Jarzebowski W; Belmin J; Lafuente-Lafuente C
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD005049. PubMed ID: 31483500
[TBL] [Abstract][Full Text] [Related]
3. The effect of antiarrhythmic medications on the risk of cardiovascular outcomes in patients with atrial fibrillation and coronary artery disease.
Wang SR; Huang KC; Lin TT; Chuang SL; Yang YY; Wu CK; Lin LY
Int J Cardiol; 2024 Aug; 409():132198. PubMed ID: 38782070
[TBL] [Abstract][Full Text] [Related]
4. Safety and Effectiveness of Rivaroxaban in Combination with Various Antiarrhythmic Drugs in Patients with Non-Permanent Atrial Fibrillation.
Chiou WR; Huang CC; Lin PL; Chuang JY; Liu LY; Su MI; Liao FC; Chen CY; Kuo JY; Tsai CT; Wu YJ; Lee YH
Am J Cardiovasc Drugs; 2021 Jul; 21(4):459-469. PubMed ID: 33369716
[TBL] [Abstract][Full Text] [Related]
5. Assessing the Risk for Peripheral Neuropathy in Patients Treated With Dronedarone Compared With That in Other Antiarrhythmics.
Wu C; Tcherny-Lessenot S; Dai W; Wang Y; Kechemir H; Gandhi S; Lin S; Juhaeri J
Clin Ther; 2018 Mar; 40(3):450-455.e1. PubMed ID: 29500139
[TBL] [Abstract][Full Text] [Related]
6. Dronedarone for the treatment of atrial fibrillation and atrial flutter.
Maund E; McKenna C; Sarowar M; Fox D; Stevenson M; Pepper C; Palmer S; Woolacott N
Health Technol Assess; 2010 Oct; 14(Suppl. 2):55-62. PubMed ID: 21047492
[TBL] [Abstract][Full Text] [Related]
7. Risk for Bleeding-Related Hospitalizations During Use of Amiodarone With Apixaban or Rivaroxaban in Patients With Atrial Fibrillation : A Retrospective Cohort Study.
Ray WA; Chung CP; Stein CM; Smalley W; Zimmerman E; Dupont WD; Hung AM; Daugherty JR; Dickson AL; Murray KT
Ann Intern Med; 2023 Jun; 176(6):769-778. PubMed ID: 37216662
[TBL] [Abstract][Full Text] [Related]
8. Clinical and economic outcomes associated with use of anti-arrhythmic drugs versus ablation in atrial fibrillation.
Ken-Opurum J; Srinivas SS; Park S; Charland S; Revel A; Preblick R
J Comp Eff Res; 2023 Aug; 12(8):e230065. PubMed ID: 37387403
[No Abstract] [Full Text] [Related]
9. International cohort study on the effectiveness of dronedarone and other antiarrhythmic drugs for atrial fibrillation in real-world practice (EFFECT-AF).
Khachatryan A; Merino JL; de Abajo FJ; Botto GL; Kirchhof P; Breithardt G; Stambler B; Abenhaim L; Grimaldi-Bensouda L
Europace; 2022 Jul; 24(6):899-909. PubMed ID: 34792111
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the cost-effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia.
Tesic D; Kostic M; Paunovic D; Jankovic SM
Kardiol Pol; 2015; 73(4):287-95. PubMed ID: 25428811
[TBL] [Abstract][Full Text] [Related]
11. Ventricular arrhythmia and death among atrial fibrillation patients using anti-arrhythmic drugs.
Friberg L
Am Heart J; 2018 Nov; 205():118-127. PubMed ID: 30236980
[TBL] [Abstract][Full Text] [Related]
12. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
[TBL] [Abstract][Full Text] [Related]
13. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
Lafuente-Lafuente C; Valembois L; Bergmann JF; Belmin J
Cochrane Database Syst Rev; 2015 Mar; (3):CD005049. PubMed ID: 25820938
[TBL] [Abstract][Full Text] [Related]
14. Dronedarone Versus Sotalol in Antiarrhythmic Drug-Naive Veterans With Atrial Fibrillation.
Pundi K; Fan J; Kabadi S; Din N; Blomström-Lundqvist C; Camm AJ; Kowey P; Singh JP; Rashkin J; Wieloch M; Turakhia MP; Sandhu AT
Circ Arrhythm Electrophysiol; 2023 Aug; 16(8):456-467. PubMed ID: 37485722
[TBL] [Abstract][Full Text] [Related]
15. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
[TBL] [Abstract][Full Text] [Related]
16. Impact of dronedarone on the risk of myocardial infarction and stroke in atrial fibrillation patients followed in general practices in Germany.
Ehrlich JR; Look C; Kostev K; Israel CW; Goette A
Int J Cardiol; 2019 Mar; 278():126-132. PubMed ID: 30528621
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation.
Cha MJ; Choi EK; Han KD; Lee SR; Lim WH; Oh S; Lip GYH
Stroke; 2017 Nov; 48(11):3040-3048. PubMed ID: 28974629
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness of antiarrhythmic drugs for rhythm control of atrial fibrillation.
Qin D; Leef G; Alam MB; Rattan R; Munir MB; Patel D; Khattak F; Adelstein E; Jain SK; Saba S
J Cardiol; 2016 May; 67(5):471-6. PubMed ID: 26233885
[TBL] [Abstract][Full Text] [Related]
19. Association Between Use of Non-Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation.
Chang SH; Chou IJ; Yeh YH; Chiou MJ; Wen MS; Kuo CT; See LC; Kuo CF
JAMA; 2017 Oct; 318(13):1250-1259. PubMed ID: 28973247
[TBL] [Abstract][Full Text] [Related]
20. Dronedarone for the treatment of atrial fibrillation: a NICE single technology appraisal.
McKenna C; Maund E; Sarowar M; Fox D; Stevenson M; Pepper C; Woolacott N; Palmer S
Pharmacoeconomics; 2012 Jan; 30(1):35-46. PubMed ID: 22136303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
